Julia Wynn, MS; Wendy K. Chung, MD, PhD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-1045.
Requests for Single Reprints: Wendy K. Chung, MD, PhD, Columbia University Medical Center, 1150 St. Nicholas Avenue, Room 620, New York, NY 10032; e-mail, firstname.lastname@example.org.
Current Author Addresses: Ms. Wynn and Dr. Chung: Columbia University Medical Center, 1150 St. Nicholas Avenue, Room 620, New York, NY 10032.
Author Contributions: Conception and design: J. Wynn, W.K. Chung.
Drafting of the article: J. Wynn, W.K. Chung.
Critical revision of the article for important intellectual content: J. Wynn, W.K. Chung.
Final approval of the article: J. Wynn, W.K. Chung.
Administrative, technical, or logistic support: J. Wynn.
Wynn J, Chung WK. 23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility. Ann Intern Med. 2017;167:125–126. [Epub ahead of print 30 May 2017]. doi: 10.7326/M17-1045
Download citation file:
Published: Ann Intern Med. 2017;167(2):125-126.
Published at www.annals.org on 30 May 2017
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use